Gratia Capital’s Aehr Test Systems AEHR Stock Holding History

Gratia Capital’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.3M	Sell	575,500 -121,500	-17%	-$11.1M	33.43%	1
2026 Q1	$25.8M	Buy	697,000 +297,000	+74%	+$9.5M	11.38%	2
2025 Q4	$8.08M	Hold	400,000	–	–	6.02%	5
2025 Q3	$12M	Buy	+400,000	New	+$8.66M	8.64%	2

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Gratia Capital's AEHR Position: Q2 2026 in Review

Gratia Capital sold out of Aehr Test Systems (AEHR) in Q2 2026, closing a stake of 51,560 shares — an estimated $4.71M sold.

Gratia Capital first reported a position in AEHR in Q3 2025 and held it in 3 quarters. The position peaked at $4.2M in Q3 2025. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Gratia Capital reported no remaining Aehr Test Systems position as of Q2 2026 after selling out during the quarter.
Gratia Capital sold 51,560 Aehr Test Systems shares in Q2 2026, an estimated $4.71M.
Gratia Capital first reported a position in Aehr Test Systems in Q3 2025 and held it in 3 quarters.
Gratia Capital's Aehr Test Systems position peaked at $4.2M in Q3 2025.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Gratia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.